Pharma firms are treading carefully as AI promises to speed up drug discovery and make clinical trials smarter, but regulatory hurdles and FDA guidance keep them cautious. Hear insights from Axtria’s Manish Mittal on balancing innovation with compliance. #AIDrugDiscovery #MachineLearningTrials #FDARegulation #AxtriaInsights

🔗 https://aidailypost.com/news/pharma-cautious-ai-promises-faster-drug-discovery-smarter-trials